Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: Role of 67 kDa laminin receptor

Tongguang Wang, Wei Zhang, Zhong Pei, Michelle Block, Belinda Wilson, Jeffrey M. Reece, David S. Miller, Jau Shyong Hong

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

It has been reported that extracellular matrix (ECM) molecules regulate monocyte activation by binding with a 67 kDa nonintegrin laminin receptor (LR). As microgliosis is a pivotal factor in propelling the progress of chronic neurodegeneration in the brain, we hypothesized that LR may regulate the microgliosis and subsequent neurotoxicity. Using 1-methyl-4-phenylpyridinium (MPP+) -treated C57 mice primary mesencephalic neuron-glia cultures as an in vitro Parkinson's disease (PD) model, we observed that MPP+ treatment increased LR expression only in the mixed neuron-glia but not in microglia-enriched or microglia-depleted cultures, indicating that MPP +-induced increase of LR expression is associated with neuronmicroglia interaction. Using confocal microscopic examination, we found that LR was localized in the microglia, which were F4/80 positive. Treatment with the antibody (Ab) against LR (LR-Ab) or YIGSR, a synthetic pentapeptide inhibitor for LR, significantly attenuated the MPP+-increased F4/80 immunoreactivity (24 h) and dopaminergic (DA) neurotoxicity. LR-Ab also attenuated MPP+-increased microglial phagocytotic activity (48 h) and the superoxide production (4 days). Further study demonstrated that exogenous laminin (1-10 μg/ml) treatment induced microglial activation and DA neurotoxicity, in a dose-dependent manner, which was partially attenuated by the LR-Ab. We concluded that by regulating cell-ECM interaction, LR plays important roles in mediating microgliosis and subsequent DA neurotoxicity. Laminin is a potential ligand for activating this LR receptor. This study also suggests that laminin/LR is a potential target for developing new therapeutic drugs against neurodegenerative disorders such as PD.

Original languageEnglish (US)
Pages (from-to)906-915
Number of pages10
JournalFASEB Journal
Volume20
Issue number7
DOIs
StatePublished - May 2006
Externally publishedYes

Fingerprint

Laminin Receptors
laminin
receptors
neurotoxicity
Microglia
neuroglia
Antibodies
Laminin
antibodies
Neuroglia
tyrosyl-isoleucyl-glycyl-seryl-arginine
Parkinson disease
Neurons
Extracellular Matrix
Parkinson Disease
extracellular matrix
Chemical activation
1-Methyl-4-phenylpyridinium
neurons
Superoxides

Keywords

  • Extracellular matrix
  • Laminin receptor
  • Microglia
  • MPP
  • Neuron
  • Parkinson's disease

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration : Role of 67 kDa laminin receptor. / Wang, Tongguang; Zhang, Wei; Pei, Zhong; Block, Michelle; Wilson, Belinda; Reece, Jeffrey M.; Miller, David S.; Hong, Jau Shyong.

In: FASEB Journal, Vol. 20, No. 7, 05.2006, p. 906-915.

Research output: Contribution to journalArticle

Wang, Tongguang ; Zhang, Wei ; Pei, Zhong ; Block, Michelle ; Wilson, Belinda ; Reece, Jeffrey M. ; Miller, David S. ; Hong, Jau Shyong. / Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration : Role of 67 kDa laminin receptor. In: FASEB Journal. 2006 ; Vol. 20, No. 7. pp. 906-915.
@article{b95b8bb0176c4032bd86134c247e2fca,
title = "Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: Role of 67 kDa laminin receptor",
abstract = "It has been reported that extracellular matrix (ECM) molecules regulate monocyte activation by binding with a 67 kDa nonintegrin laminin receptor (LR). As microgliosis is a pivotal factor in propelling the progress of chronic neurodegeneration in the brain, we hypothesized that LR may regulate the microgliosis and subsequent neurotoxicity. Using 1-methyl-4-phenylpyridinium (MPP+) -treated C57 mice primary mesencephalic neuron-glia cultures as an in vitro Parkinson's disease (PD) model, we observed that MPP+ treatment increased LR expression only in the mixed neuron-glia but not in microglia-enriched or microglia-depleted cultures, indicating that MPP +-induced increase of LR expression is associated with neuronmicroglia interaction. Using confocal microscopic examination, we found that LR was localized in the microglia, which were F4/80 positive. Treatment with the antibody (Ab) against LR (LR-Ab) or YIGSR, a synthetic pentapeptide inhibitor for LR, significantly attenuated the MPP+-increased F4/80 immunoreactivity (24 h) and dopaminergic (DA) neurotoxicity. LR-Ab also attenuated MPP+-increased microglial phagocytotic activity (48 h) and the superoxide production (4 days). Further study demonstrated that exogenous laminin (1-10 μg/ml) treatment induced microglial activation and DA neurotoxicity, in a dose-dependent manner, which was partially attenuated by the LR-Ab. We concluded that by regulating cell-ECM interaction, LR plays important roles in mediating microgliosis and subsequent DA neurotoxicity. Laminin is a potential ligand for activating this LR receptor. This study also suggests that laminin/LR is a potential target for developing new therapeutic drugs against neurodegenerative disorders such as PD.",
keywords = "Extracellular matrix, Laminin receptor, Microglia, MPP, Neuron, Parkinson's disease",
author = "Tongguang Wang and Wei Zhang and Zhong Pei and Michelle Block and Belinda Wilson and Reece, {Jeffrey M.} and Miller, {David S.} and Hong, {Jau Shyong}",
year = "2006",
month = "5",
doi = "10.1096/fj.05-5053com",
language = "English (US)",
volume = "20",
pages = "906--915",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "7",

}

TY - JOUR

T1 - Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration

T2 - Role of 67 kDa laminin receptor

AU - Wang, Tongguang

AU - Zhang, Wei

AU - Pei, Zhong

AU - Block, Michelle

AU - Wilson, Belinda

AU - Reece, Jeffrey M.

AU - Miller, David S.

AU - Hong, Jau Shyong

PY - 2006/5

Y1 - 2006/5

N2 - It has been reported that extracellular matrix (ECM) molecules regulate monocyte activation by binding with a 67 kDa nonintegrin laminin receptor (LR). As microgliosis is a pivotal factor in propelling the progress of chronic neurodegeneration in the brain, we hypothesized that LR may regulate the microgliosis and subsequent neurotoxicity. Using 1-methyl-4-phenylpyridinium (MPP+) -treated C57 mice primary mesencephalic neuron-glia cultures as an in vitro Parkinson's disease (PD) model, we observed that MPP+ treatment increased LR expression only in the mixed neuron-glia but not in microglia-enriched or microglia-depleted cultures, indicating that MPP +-induced increase of LR expression is associated with neuronmicroglia interaction. Using confocal microscopic examination, we found that LR was localized in the microglia, which were F4/80 positive. Treatment with the antibody (Ab) against LR (LR-Ab) or YIGSR, a synthetic pentapeptide inhibitor for LR, significantly attenuated the MPP+-increased F4/80 immunoreactivity (24 h) and dopaminergic (DA) neurotoxicity. LR-Ab also attenuated MPP+-increased microglial phagocytotic activity (48 h) and the superoxide production (4 days). Further study demonstrated that exogenous laminin (1-10 μg/ml) treatment induced microglial activation and DA neurotoxicity, in a dose-dependent manner, which was partially attenuated by the LR-Ab. We concluded that by regulating cell-ECM interaction, LR plays important roles in mediating microgliosis and subsequent DA neurotoxicity. Laminin is a potential ligand for activating this LR receptor. This study also suggests that laminin/LR is a potential target for developing new therapeutic drugs against neurodegenerative disorders such as PD.

AB - It has been reported that extracellular matrix (ECM) molecules regulate monocyte activation by binding with a 67 kDa nonintegrin laminin receptor (LR). As microgliosis is a pivotal factor in propelling the progress of chronic neurodegeneration in the brain, we hypothesized that LR may regulate the microgliosis and subsequent neurotoxicity. Using 1-methyl-4-phenylpyridinium (MPP+) -treated C57 mice primary mesencephalic neuron-glia cultures as an in vitro Parkinson's disease (PD) model, we observed that MPP+ treatment increased LR expression only in the mixed neuron-glia but not in microglia-enriched or microglia-depleted cultures, indicating that MPP +-induced increase of LR expression is associated with neuronmicroglia interaction. Using confocal microscopic examination, we found that LR was localized in the microglia, which were F4/80 positive. Treatment with the antibody (Ab) against LR (LR-Ab) or YIGSR, a synthetic pentapeptide inhibitor for LR, significantly attenuated the MPP+-increased F4/80 immunoreactivity (24 h) and dopaminergic (DA) neurotoxicity. LR-Ab also attenuated MPP+-increased microglial phagocytotic activity (48 h) and the superoxide production (4 days). Further study demonstrated that exogenous laminin (1-10 μg/ml) treatment induced microglial activation and DA neurotoxicity, in a dose-dependent manner, which was partially attenuated by the LR-Ab. We concluded that by regulating cell-ECM interaction, LR plays important roles in mediating microgliosis and subsequent DA neurotoxicity. Laminin is a potential ligand for activating this LR receptor. This study also suggests that laminin/LR is a potential target for developing new therapeutic drugs against neurodegenerative disorders such as PD.

KW - Extracellular matrix

KW - Laminin receptor

KW - Microglia

KW - MPP

KW - Neuron

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=33744494056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744494056&partnerID=8YFLogxK

U2 - 10.1096/fj.05-5053com

DO - 10.1096/fj.05-5053com

M3 - Article

C2 - 16675848

AN - SCOPUS:33744494056

VL - 20

SP - 906

EP - 915

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 7

ER -